(Q43638451)

25 November 2017

Decreased striatal dopamine efflux after intrastriatal application of benzazepine-class D1 agonists is not mediated via dopamine receptors (English)

1 reference

25 November 2017

0 references

1 reference

Zackheim JA

1

1 reference

PubMed ID

11403986

25 November 2017

Abercrombie ED

series ordinal

2

1 reference

25 November 2017

1 April 2001

1 reference

25 November 2017

Brain Research Bulletin

1 reference

25 November 2017

54

1 reference

25 November 2017

6

1 reference

25 November 2017

603-607

1 reference

Substantia nigra D1 receptors and stimulation of striatal cholinergic interneurons by dopamine: a proposed circuit mechanism

25 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900462-2

7 January 2021

Biochemistry of somatodendritic dopamine release in substantia nigra: an in vivo comparison with striatal dopamine release.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900462-2

7 January 2021

Lasting effects of dopamine receptor agonists upon striatal dopamine release in free-moving rats: an in vivo voltammetric study.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900462-2

7 January 2021

Dopamine receptor agonists: selectivity and dopamine D1 receptor efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900462-2

7 January 2021

Neurophysiological evidence that D-1 dopamine receptor blockade attenuates postsynaptic but not autoreceptor-mediated effects of dopamine agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900462-2

7 January 2021

Direct inhibition of the N-methyl-D-aspartate receptor channel by dopamine and (+)-SKF38393.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900462-2

7 January 2021

Spontaneous release of acetylcholine in striatum is preferentially regulated by inhibitory dopamine D2 receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900462-2

7 January 2021

Drug-induced changes in the release of 3 H-monoamines from field stimulated rat brain slices.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900462-2

7 January 2021

Dopaminergic regulation of the serotonergic raphe-striatal pathway: microdialysis studies in freely moving rats

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900462-2

7 January 2021

Is inhibition of striatal synaptosomal tyrosine hydroxylation by dopamine agonists a measure of dopamine autoreceptor function?

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900462-2

7 January 2021

Biphasic effect of sigma receptor ligands on the extracellular concentration of dopamine in the striatum of the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900462-2

7 January 2021

Are presynaptic dopamine autoreceptors and postsynaptic dopamine receptors in the rabbit caudate nucleus pharmacologically different?

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900462-2

7 January 2021

In vivo receptor binding, neurochemical and functional studies with the dopamine D-1 receptor antagonist SCH23390

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900462-2

7 January 2021

Effects of locally applied D-1 and D-2 receptor agonists and antagonists studied with brain dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900462-2

7 January 2021

CY 208-243, a novel dopamine D-1 receptor agonist, fails to modify dopamine release in freely moving rats

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900462-2

7 January 2021

Continuous cocaine induces persisting alterations in dopamine overflow in caudate following perfusion with a D1 agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900462-2

7 January 2021

Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900462-2

7 January 2021

Biphasic effect of locally applied apomorphine and 2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine on the release of striatal dopamine investigated by means of brain dialysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900462-2

7 January 2021

Effects of D1 and D2 antagonists on the transient increase of dopamine release by dopamine agonists by means of brain dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900462-2

7 January 2021

Role of striatal serotonin2A and serotonin2C receptor subtypes in the control of in vivo dopamine outflow in the rat striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900462-2

7 January 2021

Effects of D-2 agonists on the release of dopamine: localization of the mechanism of action.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900462-2

7 January 2021

In vivo microdialysis evidence for transient dopamine release by benzazepines in rat striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900462-2

7 January 2021

10.1016/S0361-9230(01)00462-2

Identifiers

DOI

1 reference

release_4gljecurkndwpiqjqfrha2pcpi

25 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4gljecurkndwpiqjqfrha2pcpi

24 November 2022

mapped directly with Wikidata item

PubMed ID

11403986

1 reference

PubMed ID

11403986